Latest stories on EVAX
EVAX Stock Heads For Best Week Since January 2025 As Cancer Vaccine Shows 89% Target Precision
Stocktwits News74 · bullishproduct/pr
Evaxion Biotech presents three-year immune and clinical outcome data for EVX-01
The Fly63 · neutralproduct/pr
EVAX jumps as EVX-01 melanoma vaccine shows sustained responses at three-year follow-up
MarketChameleon74 · bullishproduct/pr
Evaxion stock surges on 3-year melanoma vaccine trial data
Investing.com Markets74 · bullishproduct/pr
EVAX jumps as EVX-01 posts sustained three-year responses with no tumor progression in advanced melanoma
October 19, 2026
MarketChameleon74 · bullishproduct/pr
Evaxion Posts Durable Three-Year Responses in Phase 2 Trial of Personalized Cancer Vaccine EVX-01
TipRanks74 · bullishproduct/pr
INTC, EVAX, RCAT Stocks Move Higher Premarket — What’s Driving The Rally?
Stocktwits News64 · neutralgeneral
Evaxion Biotech reports three-year clinical outcome data for EVX-01
The Fly63 · neutralproduct/pr
Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01
Business Insider74 · bullishproduct/pr
Evaxion Biotech to present new immune data on EVX-01 at SITC 2026
The Fly63 · neutralproduct/pr
Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
GlobeNewswire63 · neutralproduct/pr
Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
StockTitan63 · neutralproduct/pr
Evaxion applies its AI-Immunology™ platform in autoimmune diseases
GlobeNewswire63 · neutralproduct/pr
Evaxion applies its AI-Immunology™ platform in autoimmune diseases
Business Insider56 · neutralproduct/pr
Evaxion Biotech Boosts Share Capital With August 2026 ATM ADS Offering
TipRanks24 · bearishgeneral
Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery?
Yahoo Finance63 · neutralproduct/pr
Evaxion A/S 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Evaxion A/S (EVAX) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Evaxion’s R&D Milestones and Extended Cash Runway Highlight 2026 Outlook
MarketChameleon67 · bullishproduct/pr
Evaxion Biotech GAAP EPS of -$0.01 in-line
Seeking Alpha50 · neutralearnings
Evaxion announces business update and second quarter 2026 financial results
GlobeNewswire50 · neutralearnings
Evaxion announces business update and second quarter 2026 financial results
Business Insider50 · neutralearnings